The vaccine will cost about $4, and it will also be more convenient to transport and store since it does not require very low temperatures.
The coronavirus vaccine, developed by scientists at Oxford University and AstraZeneca, will be more readily available to poor countries than other vaccines. It was reported by The Guardian on Monday, 23 November.
In particular, the AstraZeneca vaccine can be transported and stored for up to six months under standard refrigeration conditions вЂ” at temperatures from +2 to +7. It will also cost about $ 4, which is several times cheaper than the Pfizer / BioNTech and Moderna vaccines.
In addition, the vaccine can still be as effective as 90% at a lower concentration in the first dose. Although the results at first glance look different from those of Pfizer and Moderna, scientists insist on the disparity, since Oxford and AstraZeneca vaccinated people in the mild to severe stage of COVID-19.
Finally, the AstraZeneca vaccine has been shown to be highly effective in both the elderly and young adults.
вЂњWe have a vaccine for the world, its effectiveness is high, it prevents serious illness and hospitalization. These are amazing results. Because this vaccine can be stored at refrigerator temperature, it can be distributed around the world using a conventional immunization system. The goal is to have a vaccine that will be available everywhere, вЂњsaid Andrew Pollard, director of the Oxford Vaccine Group.
Recall that the G20 will help equitably distribute the vaccine. G20 leaders are worried that the pandemic could further exacerbate divisions between rich and poor.
It was also reported that the G20 countries are asking $5 billion for a COVID vaccine for poor countries. Adequate funding is needed for a global strategy to overcome the pandemic, GAVI said.